Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 ...

Circulating CD28-KLRG1+CD8+ T cells as prognostic indicators in advanced NSCLC chemoimmunotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...

Individuals with post-COVID syndrome had higher immune cell counts after receiving exercise-based rehabilitation vs. usual ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Phase 1 study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors or lymphoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...

Scientists have found that preserving lymph nodes during cancer surgery could dramatically improve how patients respond to ...

As there is no cure for celiac disease, people must stick to a gluten free diet to remain symptom-free. While this has become easier in recent years, scientists have found some promising results in ...